Search

everythinglearnresearchcommunity

for

Search:↓

Sertoli cell transplants can reduce inflammation and improve sperm quality.

Microsponges delivery system is a safe, versatile method for controlled drug release in various treatments.

Intramuscular corticosteroids are effective and safe for severe alopecia areata, with most patients regrowing hair, but nearly half may relapse.

Total glucosides of paeony can help treat skin conditions but need more research for clinical use.

Systemic retinoids do not increase COVID-19 risk or severity.

Patients with fewer past treatments for alopecia areata respond better to baricitinib.

Therapy lowers IgM levels in dogs with severe dermatitis but not in mild cases.

Methotrexate with steroids is slightly more effective than azathioprine with steroids for treating severe alopecia areata.

Antimalarial agents are effective for LPP, and intralesional steroids are effective for FFA.

Intralesional triamcinolone is the most effective treatment for hair regrowth in alopecia areata patients.

Intralesional triamcinolone is the most effective treatment for alopecia areata, followed by excimer light therapy, and then topical minoxidil. The scalp responds better to treatment than the beard area.

Minoxidil 2% is more effective than tacrolimus 0.1% for hair regrowth in mild to moderate patchy hair loss, and combining both might give better results.

Changing how mesenchymal stromal cells are grown can improve their healing abilities.

The secretome from mesenchymal stem cells is a promising treatment that may repair tissue and avoid side effects of stem cell transplantation.

Thymus transplantation successfully restored immune function in infants with FOXN1 deficiency.

New methods to improve the healing abilities of mesenchymal stem cells for disease treatment are promising but need more research.

Cell-based therapies show promise for treating Limbal Stem Cell Deficiency but need more research.

Some alopecia treatments might help treat COVID-19, but more research is needed.

Targeting Keratin 17 may help overcome cancer therapy resistance.

Mesenchymal stem cells improve skin appearance and structure in dermatology and aesthetic medicine.

Tacrolimus causes fewer acute rejections than cyclosporin A in kidney transplants but doesn't necessarily improve kidney function after one year; cardiovascular risks and side effects vary between the two drugs.

Platelet-rich plasma therapy is more effective than minoxidil lotion for increasing hair count in men with hair loss, with mild side effects and high satisfaction.

Targeted cancer therapies can cause skin side effects, which should be treated early to help patients' quality of life and treatment adherence.

RANK is a key target in breast cancer treatment due to its role in tumor growth and bone metastasis.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

An 8-year-old girl with vitiligo developed extra hair growth on her knee after using tacrolimus ointment.

Liposomes show promise in cancer treatment by delivering drugs with less toxicity and improved effectiveness.

Mesenchymal stem cell therapy may help treat alopecia areata by promoting hair growth and reducing inflammation.

Botulinum toxin's effectiveness for treating scalp alopecia is not well-supported due to insufficient data.

PRP and cell therapies may help with hair loss, but more research is needed.